---
title: "Moleculin Biotech Inc. 召开了特别股东大会"
description: "Moleculin Biotech Inc. 于 2025 年 10 月 16 日召开了特别股东会议，股东们批准了与某些认股权证相关的最多发行 64,864,864 股普通股的提案。然而，将公司名称更改为 Moleculin Inc.的提案未获批准。会议还获得了对潜在延期以征集更多委托书的批准"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/261477503.md"
published_at: "2025-10-16T15:16:41.000Z"
---

# Moleculin Biotech Inc. 召开了特别股东大会

> Moleculin Biotech Inc. 于 2025 年 10 月 16 日召开了特别股东会议，股东们批准了与某些认股权证相关的最多发行 64,864,864 股普通股的提案。然而，将公司名称更改为 Moleculin Inc.的提案未获批准。会议还获得了对潜在延期以征集更多委托书的批准

Moleculin Biotech Inc. 于 2025 年 10 月 16 日召开了股东特别会议。股东批准在行使于 2025 年 8 月 28 日发行的某些认股权证时，最多发行 64,864,864 股普通股。关于将公司名称从 Moleculin Biotech, Inc. 修改为 Moleculin Inc. 的提案未获批准。会议如有必要，获准可能延期，以征求更多的委托书。免责声明：本新闻简报由公共技术公司（PUBT）使用生成性人工智能创建。尽管 PUBT 努力提供准确和及时的信息，但此 AI 生成的内容仅供参考，不应被解读为财务、投资或法律建议。Moleculin Biotech Inc. 于 2025 年 10 月 16 日通过美国证券交易委员会（SEC）运营的电子数据收集、分析和检索系统（EDGAR）发布了用于生成本新闻简报的原始内容（参考 ID：0001437749-25-031123），并对此信息的内容承担全部责任。© 版权 2025 - 公共技术公司（PUBT）原始文档：这里

### Related Stocks

- [MBRX.US - Moleculin Biotech](https://longbridge.com/zh-CN/quote/MBRX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Moleculin Biotech Raises $6.8 Million Through Warrant Exercises | Moleculin Biotech Inc. raised $6.8 million through warrant exercises, involving 727,969 shares at $6.63 per share and 31 | [Link](https://longbridge.com/zh-CN/news/269236812.md) |
| Byline Bancorp General Counsel Brian F. Doran Acquires Common Shares | Brian F. Doran, General Counsel of Byline Bancorp Inc., has acquired common shares of the company. The full filing is av | [Link](https://longbridge.com/zh-CN/news/276162067.md) |
| American Rebel Holdings Inc. Files Draft Information Statement Outlining Authorized Corporate Actions | American Rebel Holdings Inc. shareholders have approved corporate actions, including a reverse stock split and an amendm | [Link](https://longbridge.com/zh-CN/news/276159708.md) |
| Arteris Inc. CEO Charles Janac Reports Sale of Common Shares | Charles K. Janac, CEO of Arteris Inc., reported the sale of common shares as a beneficial owner. The full filing is avai | [Link](https://longbridge.com/zh-CN/news/275675466.md) |
| FormFactor Inc. Director Thomas St Dennis Sells Common Shares | Thomas St Dennis, Director at FormFactor Inc., has sold common shares of the company. The full filing is available throu | [Link](https://longbridge.com/zh-CN/news/275670858.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。